Advertisements


5 Reasons Big Biotech Could Gain 25%-30%

Leerink analyst Geoff Porges sees 25% or better upside ahead for Big Biotech. Here's why.....»»

Category: blogSource: barronsMay 19th, 2017

3 Pharma/Biotech Sector Bargains for a Healthy Portfolio

The biotech sector has turned around after its dismal performance in 2016 as uncertainty surrounding drug pricing control subsides. A few stocks are however still undervalued, which may gain going ahead. After a lackluster performanc.....»»

Category: dealsSource: nytSep 13th, 2017

U.S. stocks end higher; Nasdaq boosted by biotech gain

U.S. stocks ended higher on Wednesday, with the Nasdaq seeing a particular gain on the strength of biotechnology companies, while the S&P 500 closed higher for a fourth straight session. The Dow Jones Industrial A.....»»

Category: topSource: marketwatchAug 30th, 2017

Biotech stocks rally, ETF on track for third straight daily gain

Biotechnology stocks rallied on Wednesday, w.....»»

Category: topSource: marketwatchAug 30th, 2017

3 Reasons to Buy Aurinia Pharmaceuticals Stock Right Now

Red-hot biotech stock Aurinia Pharmaceuticals might be as cheap now as it will ever be......»»

Category: topSource: foxnewsAug 17th, 2017

Biotech ETF Industry Outlook for Second Half 2017

There are several reasons to be positive on biotech stocks and ETFs for the rest of the year. Biotech stocks have had a strong run so far in 2017 with the NASDAQ Biotechnology Ind.....»»

Category: topSource: zacksJul 24th, 2017

Carnival: 3 Reasons For Smooth Sailing

One team of analysts sees three reasons shares of Carnival can continue to rise despite their big gain this year......»»

Category: blogSource: barronsJul 5th, 2017

After Bluebird"s 75% Gain In 2017, Analysts At BTIG Downgrade To Neutral

Shares of bluebird bio Inc (NASDAQ: BLUE) have gained 75 percent since the start of 2017, which prompted analysts at BTIG to downgrade the biotech company at the forefront of fighting against cancer. Latest Ratings for BL.....»»

Category: blogSource: benzingaJun 30th, 2017

Forget Big Tech, Biotech ETFs are Soaring Higher

Biotech stocks are surging of late; we discuss the reasons behind the rebound and highlight the best performing ETFs. Biotech stocks have been surging over the past 2-3 weeks, as the high-flying tech stocks.....»»

Category: topSource: zacksJun 29th, 2017

4 Reasons Coach Can Gain 20%

Shares of Coach are gaining today after Buckingham Research upgraded the stock to Buy......»»

Category: blogSource: barronsJun 26th, 2017

Go, Gilead, Go!

After lagging other biotech stocks, shares of Gilead Sciences are on pace for their biggest two-day gain since 2012......»»

Category: blogSource: barronsJun 22nd, 2017

5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher. The biotech sector is going through the roof right now with SPDR S&P Biotech ETF XBI adding over 9.4.....»»

Category: topSource: zacksJun 22nd, 2017

Biotech ETF IBB on pace for best weekly gain in 7 months

A popular fund used to invest in the biotechnology sec.....»»

Category: topSource: marketwatchJun 22nd, 2017

Biotech ETF IBB on pace for best weekly gain 7 months

A popular fund used to invest in the biotechnology sec.....»»

Category: topSource: marketwatchJun 22nd, 2017

5 reasons to buy biotech stocks now

The medical gains are off the charts and won’t be stifled by a slowing economy, says Michael Brush......»»

Category: topSource: moneycentralJun 20th, 2017

Five reasons you have to buy biotech stocks now

The medical gains are off the charts and won’t be stifled by a slowing economy, says Michael Brush......»»

Category: topSource: marketwatchJun 20th, 2017

6 Reasons to Add Apogee (APOG) Stock to Your Portfolio Now

Apogee (APOG) is poised to gain from positive estimate revi.....»»

Category: topSource: zacksJun 19th, 2017

Why Protagonist Therapeutics Shares Are Climbing

Protagonist Therapeutics saw its shares make a solid gain early on Tuesday after the company announced a key worldwide licensing and collaboration agreement with Janssen Biotech......»»

Category: blogSource: 247wallstMay 30th, 2017

6 Reasons to Add Deere & Company (DE) Stock to Your Portfolio

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Deere (DE) stock is poised to gain from positive estimate revisions and upbeat outlook. The post 6 Reasons to Add Deere & Company (DE) Stock to Your Portfolio appeared first on InvestorPlace......»»

Category: topSource: investorplaceMay 30th, 2017

7 Reasons to Add Rockwell Automation to Your Portfolio Now

Rockwell Automation (ROK) is poised to gain from positive estimate revisions and outlook. Shares of Rockwell Automation Inc. ROK, the original.....»»

Category: topSource: zacksMay 18th, 2017

Biotech Forum Daily Digest: Keytruda Continues To Gain Momentum. Revisiting Amicus Therapeutics After Earnings

Biotech Forum Daily Digest: Keytruda Continues To Gain Momentum. Revisiting Amicus Therapeutics After Earnings.....»»

Category: topSource: seekingalphaMay 12th, 2017